ANTI-INFLAMMATORY BOTANICAL PRODUCTS FOR THE TREATMENT OF METABOLIC SYNDROME AND DIABETES
Disclosed are botanically based compositions and methods useful for the treatment of metabolic syndrome and diabetes type 2. Compositions, kits, and methods are additionally disclosed for means to augment the activity of identified glucose and insulin regulating drugs.
1 - 5 . (canceled)
6 . A method for adipocyte modification for the treatment of insulin related disorders in a subject in need thereof, said method comprising administering to the subject a composition comprising a therapeutically effective amount of a pharmaceutically acceptable botanical product, wherein the botanical product is a compound or extract derived from acacia or hops, wherein
a. wherein the acacia derived botanical product is derived from Acacia catechu or Acacia nilotica ; and
b. wherein the botanical product derived from hops is selected from the group consisting of prenylflavonoids, chalcones, reduced isoalpha acids, dihydro-isoalpha acids, tetra-hydroisoalpha acids, hexa-hydroisoalpha acids, xanthohumol, isoxanthohumol, 6-prenylnaringen, and 8-prenylnaringenin.
7 . A composition for adipocyte modification for the treatment of insulin related disorders in a subject in need thereof, said composition comprising a therapeutically effective amount of a pharmaceutically acceptable botanical product, wherein the botanical product is a compound or extract derived from acacia or hops, wherein
a. wherein the acacia derived botanical product is derived from Acacia catechu or Acacia nilotica ; and
b. wherein the botanical product derived from hops is selected from the group consisting of prenylflavonoids, chalcones, reduced isoalpha acids, dihydro-isoalpha acids, tetra-hydroisoalpha acids, hexa-hydroisoalpha acids, xanthohumol, isoxanthohumol, 6-prenylnaringen, and 8-prenylnaringenin.